<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bio Product Guide &#187; pain relief</title>
	<atom:link href="http://www.bioproductguide.com/blog/tag/pain-relief/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioproductguide.com/blog</link>
	<description>A comprehensive guide to bio products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 08:56:43 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>EUFLEXXA(R) superior to IA saline for pain relief in knee OA</title>
		<link>http://www.bioproductguide.com/blog/2008/10/30/euflexxar-superior-to-ia-saline-for-pain-relief-in-knee-oa/</link>
		<comments>http://www.bioproductguide.com/blog/2008/10/30/euflexxar-superior-to-ia-saline-for-pain-relief-in-knee-oa/#comments</comments>
		<pubDate>Thu, 30 Oct 2008 07:15:04 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Research]]></category>
		<category><![CDATA[osteoarthritis]]></category>
		<category><![CDATA[EUFLEXXA(R)]]></category>
		<category><![CDATA[Ferring Pharmaceuticals Inc.]]></category>
		<category><![CDATA[IA saline]]></category>
		<category><![CDATA[knee]]></category>
		<category><![CDATA[pain relief]]></category>

		<guid isPermaLink="false">http://www.bioproductguide.com/blog/2008/10/30/euflexxar-superior-to-ia-saline-for-pain-relief-in-knee-oa/</guid>
		<description><![CDATA[Ferring Pharmaceuticals Inc. has presented results from the FLEXX Trial of Osteoarthritis (OA) of the Knee at the Osteoarthritis Research Society International 2008 World Congress in Rome, Italy. The results show that EUFLEXXA(R), a highly pure non-avian high molecular weight form of intra-articular hyaluronic acid, is superior to intra-articular saline for pain relief in knee [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.ferringusa.com"><img src="http://www.bioproductguide.com/blog/wp-content/uploads/2008/10/ferring.png" align="left" height="86" hspace="5" vspace="5" width="200" />Ferring Pharmaceuticals Inc.</a> has presented results from the FLEXX Trial of Osteoarthritis (OA) of the Knee at the Osteoarthritis Research Society International 2008 World Congress in Rome, Italy. The results show that EUFLEXXA(R), a highly pure non-avian high molecular weight form of intra-articular hyaluronic acid, is superior to intra-articular saline for pain relief in knee OA at the end of six months. The double-blind study had enrolled 586 patients. EUFLEXXA is the first hyaluronic acid derived from non-avian that has been approved in the U.S. for knee OA pain.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bioproductguide.com/blog/2008/10/30/euflexxar-superior-to-ia-saline-for-pain-relief-in-knee-oa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
